Goodblend Pennsylvania LLC, a subsidiary of the privately held, vertically integrated company Parallel Cannabis, opted to exit the medical marijuana market in the Keystone State.
What Happened
The cannabis operator announced this week that it's closing its two cannabis dispensaries in Friendship and Erie and a processing facility in Pittsburgh, which cost its 76 workers their jobs, reported Pittsburgh Post-Gazette.
"In connection with a strategic review, we have made the decision to withdraw from the Pennsylvania market in order to serve patients in our other, more established markets," Sam Schwartz, a Parallel spokesman, told the Post-Gazette.
What's Next
Goodblend notified the state that it would discontinue its operations effective September 15.
In an emailed statement, the company said they seek to provide their personnel "with support during this transition."
"Parallel/Goodblend is working with regulators to establish and execute a closure plan over the next 60 days," the company said.
The Background
According to Green Market Report, the move comes on the heels of financial difficulties that prompted a lawsuit from the company's landlord, Innovative Industrial Properties Inc. IIPR.
Parallel and Innovative are entangled in a legal dispute in the local court this month. Parallel allegedly breached a 20-year lease agreement for its Beaver Avenue facility, having failed to make the monthly rent since November of 2022, owing roughly $6 million in total.
MMJ Research Partnership With Pitt
On a more positive note, Parallel also announced it has partnered with the University of Pittsburgh over a clinical research program. The deal was approved by the Pennsylvania Department of Health in 2020.
The 10-year collaboration between the medical school and Parallel, and its subsidiary Goodblend, will provide $3 million to study the safety and efficacy of medical cannabis. Their efforts will be focused on sickle cell disease, chronic pain and generalized anxiety disorders.
The Benzinga Cannabis Capital Conference, the place where deals get done, is returning to Chicago this Sept 27-28 for its 17th edition. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.
Photo: Courtesy of Kindel Media by Pexels
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!